
Scott Dodds
Examiner (ID: 5800, Phone: (571)270-7653 , Office: P/1746 )
| Most Active Art Unit | 1746 |
| Art Unit(s) | 1791, 1746 |
| Total Applications | 996 |
| Issued Applications | 635 |
| Pending Applications | 97 |
| Abandoned Applications | 283 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7328472
[patent_doc_number] => 20040253665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Novel peptide-producing enzyme, microbe producing the enzyme and method for dipeptide synthesis using them'
[patent_app_type] => new
[patent_app_number] => 10/819941
[patent_app_country] => US
[patent_app_date] => 2004-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13608
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20040253665.pdf
[firstpage_image] =>[orig_patent_app_number] => 10819941
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/819941 | Novel peptide-producing enzyme, microbe producing the enzyme and method for dipeptide synthesis using them | Apr 7, 2004 | Abandoned |
Array
(
[id] => 5631011
[patent_doc_number] => 20060147480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant'
[patent_app_type] => utility
[patent_app_number] => 10/551840
[patent_app_country] => US
[patent_app_date] => 2004-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14824
[patent_no_of_claims] => 143
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20060147480.pdf
[firstpage_image] =>[orig_patent_app_number] => 10551840
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/551840 | Liquid pharmaceutical formulations of FSH and LH together with a non-ionic surfactant | Apr 1, 2004 | Issued |
Array
(
[id] => 7161604
[patent_doc_number] => 20050084943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'New conditions for reactions mediated by yeast'
[patent_app_type] => utility
[patent_app_number] => 10/814891
[patent_app_country] => US
[patent_app_date] => 2004-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4576
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20050084943.pdf
[firstpage_image] =>[orig_patent_app_number] => 10814891
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/814891 | Conditions for reactions mediated by yeast | Mar 30, 2004 | Issued |
Array
(
[id] => 7351048
[patent_doc_number] => 20040248769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Enzyme inhibitors for inactivating allergens'
[patent_app_type] => new
[patent_app_number] => 10/487657
[patent_app_country] => US
[patent_app_date] => 2004-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4469
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248769.pdf
[firstpage_image] =>[orig_patent_app_number] => 10487657
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/487657 | Enzyme inhibitors for inactivating allergens | Feb 19, 2004 | Abandoned |
Array
(
[id] => 5700615
[patent_doc_number] => 20060217300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Analogues of glp-1'
[patent_app_type] => utility
[patent_app_number] => 10/546303
[patent_app_country] => US
[patent_app_date] => 2004-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25444
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20060217300.pdf
[firstpage_image] =>[orig_patent_app_number] => 10546303
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/546303 | Analogues of glp-1 | Feb 16, 2004 | Abandoned |
Array
(
[id] => 7432204
[patent_doc_number] => 20040162242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-19
[patent_title] => 'Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/778756
[patent_app_country] => US
[patent_app_date] => 2004-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21221
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20040162242.pdf
[firstpage_image] =>[orig_patent_app_number] => 10778756
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/778756 | Inhibitors of antigen presentation by MHC class II molecules and methods of use thereof | Feb 12, 2004 | Issued |
Array
(
[id] => 7326867
[patent_doc_number] => 20040253226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases'
[patent_app_type] => new
[patent_app_number] => 10/777998
[patent_app_country] => US
[patent_app_date] => 2004-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15233
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20040253226.pdf
[firstpage_image] =>[orig_patent_app_number] => 10777998
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/777998 | Compositions and methods for inhibiting endothelial cell proliferation and regulating angiogenesis using serine proteases | Feb 11, 2004 | Abandoned |
Array
(
[id] => 74625
[patent_doc_number] => 07750117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-06
[patent_title] => 'Methods for heat-stabilizing proteins with specific binding activities'
[patent_app_type] => utility
[patent_app_number] => 10/777825
[patent_app_country] => US
[patent_app_date] => 2004-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3106
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/750/07750117.pdf
[firstpage_image] =>[orig_patent_app_number] => 10777825
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/777825 | Methods for heat-stabilizing proteins with specific binding activities | Feb 10, 2004 | Issued |
Array
(
[id] => 4872705
[patent_doc_number] => 20080199439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'IAP-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods'
[patent_app_type] => utility
[patent_app_number] => 10/777946
[patent_app_country] => US
[patent_app_date] => 2004-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9834
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20080199439.pdf
[firstpage_image] =>[orig_patent_app_number] => 10777946
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/777946 | IAP-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods | Feb 10, 2004 | Abandoned |
Array
(
[id] => 668519
[patent_doc_number] => 07094760
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-22
[patent_title] => 'Peptides for treatment of inflammation and shock'
[patent_app_type] => utility
[patent_app_number] => 10/773229
[patent_app_country] => US
[patent_app_date] => 2004-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10277
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/094/07094760.pdf
[firstpage_image] =>[orig_patent_app_number] => 10773229
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/773229 | Peptides for treatment of inflammation and shock | Feb 8, 2004 | Issued |
Array
(
[id] => 7351289
[patent_doc_number] => 20040248808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Methods for preventing mitochondrial permeability transition'
[patent_app_type] => new
[patent_app_number] => 10/771232
[patent_app_country] => US
[patent_app_date] => 2004-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 11290
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248808.pdf
[firstpage_image] =>[orig_patent_app_number] => 10771232
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/771232 | Methods for preventing mitochondrial permeability transition | Feb 2, 2004 | Issued |
Array
(
[id] => 7155892
[patent_doc_number] => 20050026840
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or pertidomimetics'
[patent_app_type] => utility
[patent_app_number] => 10/764288
[patent_app_country] => US
[patent_app_date] => 2004-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15369
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20050026840.pdf
[firstpage_image] =>[orig_patent_app_number] => 10764288
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/764288 | Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics | Jan 22, 2004 | Issued |
Array
(
[id] => 7325042
[patent_doc_number] => 20040138110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'Inhibitors of the urokinase receptor'
[patent_app_type] => new
[patent_app_number] => 10/756289
[patent_app_country] => US
[patent_app_date] => 2004-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5414
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20040138110.pdf
[firstpage_image] =>[orig_patent_app_number] => 10756289
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/756289 | Inhibitors of the urokinase receptor | Jan 13, 2004 | Abandoned |
Array
(
[id] => 6972520
[patent_doc_number] => 20050038230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Linear and cyclic melanocortin receptor-specific peptides'
[patent_app_type] => utility
[patent_app_number] => 10/756212
[patent_app_country] => US
[patent_app_date] => 2004-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12236
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20050038230.pdf
[firstpage_image] =>[orig_patent_app_number] => 10756212
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/756212 | Linear and cyclic melanocortin receptor-specific peptides | Jan 11, 2004 | Issued |
Array
(
[id] => 7424124
[patent_doc_number] => 20040208824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/742634
[patent_app_country] => US
[patent_app_date] => 2003-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 61824
[patent_no_of_claims] => 123
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20040208824.pdf
[firstpage_image] =>[orig_patent_app_number] => 10742634
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/742634 | Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof | Dec 21, 2003 | Abandoned |
Array
(
[id] => 7424124
[patent_doc_number] => 20040208824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/742634
[patent_app_country] => US
[patent_app_date] => 2003-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 61824
[patent_no_of_claims] => 123
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20040208824.pdf
[firstpage_image] =>[orig_patent_app_number] => 10742634
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/742634 | Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof | Dec 21, 2003 | Abandoned |
Array
(
[id] => 679973
[patent_doc_number] => 07084112
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-01
[patent_title] => 'Activated polyethylene glycol compounds'
[patent_app_type] => utility
[patent_app_number] => 10/741496
[patent_app_country] => US
[patent_app_date] => 2003-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8380
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/084/07084112.pdf
[firstpage_image] =>[orig_patent_app_number] => 10741496
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/741496 | Activated polyethylene glycol compounds | Dec 18, 2003 | Issued |
Array
(
[id] => 5754607
[patent_doc_number] => 20060223756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-05
[patent_title] => 'Endothelial cell specifically binding peptides'
[patent_app_type] => utility
[patent_app_number] => 10/537847
[patent_app_country] => US
[patent_app_date] => 2003-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23772
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20060223756.pdf
[firstpage_image] =>[orig_patent_app_number] => 10537847
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/537847 | Endothelial cell specifically binding peptides | Dec 16, 2003 | Abandoned |
Array
(
[id] => 7675721
[patent_doc_number] => 20040126397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Use of the neurotoxic component of a botulinum toxin for treating various disorders and conditions and associated pain'
[patent_app_type] => new
[patent_app_number] => 10/726904
[patent_app_country] => US
[patent_app_date] => 2003-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5514
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0126/20040126397.pdf
[firstpage_image] =>[orig_patent_app_number] => 10726904
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/726904 | Use of the neurotoxic component of a botulinum toxin for treating a spastic muscle | Dec 1, 2003 | Issued |
Array
(
[id] => 7148106
[patent_doc_number] => 20040170625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Methods of treating Epidermolysis Bullosa and associated dermatological indications with thymosin beta 4, analogues, isoforms and other derivatives'
[patent_app_type] => new
[patent_app_number] => 10/714405
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2746
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20040170625.pdf
[firstpage_image] =>[orig_patent_app_number] => 10714405
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/714405 | Methods of treating Epidermolysis Bullosa and associated dermatological indications with thymosin beta 4, analogues, isoforms and other derivatives | Nov 16, 2003 | Abandoned |